BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.213
+0.002 (1.14%)
At close: Mar 6, 2026, 4:00 PM EST
0.214
+0.001 (0.66%)
After-hours: Mar 6, 2026, 7:57 PM EST
BioRestorative Therapies Employees
BioRestorative Therapies had 11 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$34,855
Profits / Employee
-$1,151,862
Market Cap
4.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| GeoVax Labs | 17 |
| VivoSim Labs | 14 |
| Genprex | 13 |
| Revelation Biosciences | 9 |
| MetaVia | 9 |
| Indaptus Therapeutics | 7 |
| Galmed Pharmaceuticals | 6 |
| Silo Pharma | 3 |
BRTX News
- 3 days ago - BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 - GlobeNewsWire
- 12 days ago - BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs - GlobeNewsWire
- 23 days ago - BioRestorative Announces Closing of $5.0 Million Public Offering - GlobeNewsWire
- 25 days ago - BioRestorative Announces Pricing of $5.0 Million Public Offering - GlobeNewsWire
- 25 days ago - BioRestorative Announces Positive Outcome from Type B Meeting with FDA - GlobeNewsWire
- 4 months ago - BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 - GlobeNewsWire
- 4 months ago - BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market - GlobeNewsWire